Extracellular signal-regulated kinase 1/2 mitogen-activated protein kinase pathway is involved in myostatin-regulated differentiation repression

Cancer Research

Volumn 66, Issue 3, 2006, Pages 1320-1326

  Yang, Wei ^a   Chen, Yan ^c   Zhang, Yong ^a   Wang, Xueyan ^a   Yang, Ning ^b   Zhu, Dahai ^a,c  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b CHINA AGRICULTURAL UNIVERSITY   (China)

^c HARBIN INSTITUTE OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ACTIVIN RECEPTOR 2; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MYOSTATIN; RECOMBINANT PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL DIFFERENTIATION; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; FEMALE; IMMUNOFLUORESCENCE; MOUSE; MUSCLE CELL; MYOBLAST; NONHUMAN; ONCOGENE RAS; PRIORITY JOURNAL; WESTERN BLOTTING;

ACTIVIN RECEPTORS, TYPE II; ANIMALS; CELL DIFFERENTIATION; CELL GROWTH PROCESSES; CELL LINE; DOWN-REGULATION; ENZYME ACTIVATION; FEMALE; MAP KINASE SIGNALING SYSTEM; MICE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MYOBLASTS; PHOSPHORYLATION; RAS PROTEINS; RECOMBINANT PROTEINS; RNA, SMALL INTERFERING; TRANSFORMING GROWTH FACTOR BETA;

EID: 32944477055     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1242/jcs.02836     Document Type: Article

References (36)

1. McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-β super-family member. Nature 1997;387:83-90.
2. Grobet L, Martin LJ, Poncelet D, et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997;17:71-4.
3. Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002;52:832-6.
4. Bogdanovich S, Krag TO, Barton ER, et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002;420:418-21.
5. Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004;350:2682-8.
6. Zimmers TA, Davies MV, Koniaris LG, et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002;296:1486-8.
7. Reardon KA, Davis J, Kapsa RM, Choong P, Byrne E. Myostatin, insulin-lilte growth factor-1, and leukemia inhibitory factor mRNAs are up-regulated in chronic human disuse muscle atrophy. Muscle Nerve 2001;24:893-9.
8. Gonzalez-Cadavid NF, Taylor WE, Yarasheski K, et al. Organization of the human myostatin gene and expression in healthy men and HIV-infected men with muscle wasting. Proc Natl Acad Sci U S A 1998;95:14938-43.
9. Ivey FM, Roth SM, Ferrell RE, et al. Effects of age, gender, and myostatin genotype on the hypertrophic response to heavy resistance strength training. J Gerontol A Biol Sci Med Sci 2000;55:M641-8.
10. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol 2004;20:61-86.
11. Thomas M, Langley B, Berry C. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000;275:40235-43.
12. Langley B, Thomas M, McFarlane C, Gilmour S, Sharma M, Kambadur R. Myostatin inhibits rhabdomyo-sarcoma cell proliferation through an Rb-independent pathway. Oncogene 2004;23:524-34.
13. Langley B, Thomas M, Bishop A, Sharma M, Gilmour S, Kambadur R. Myostatin inhibits myoblast differentiation by down-regulating MyoD expression. J Biol Chem 2002;277:49831-40.
14. Rebbapragada A, Benchabane H, Wrana JL, Celeste AJ, Attisano L. Myostatin signals through a transforming growth factor β-like signaling pathway to block adipogenesis. Mol Cell Biol 2003;23:7230-42.
15. Philip B, Lu Z, Gao Y. Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 2005;17:365-75.
16. Borycki AG, Emerson CP. Muscle determination: another key player in myogenesis? Curr Biol 1997;7: R620-3.
17. Molkentin JD, Olson EN. Defining the regulatory networks for muscle development. Curr Opin Genet Dev 1996;6:445-53.
18. Weintraub H, Davis R, Tapscott S, et al. The myoD gene family: nodal point during specification of the muscle cell lineage. Science 1991;251:761-6.
19. Olson EN, Klein WH. bHLH factors in muscle development; dead lines and commitments, what to leave in and what to leave out. Genes Dev 1994;8:1-8.
20. Tortorella LL, Milasincic DJ, Pilch PF. Critical proliferation- independent window for basic fibroblast growth factor repression of myogenesis via the p42/p44 MAPK signaling pathway. J Biol Chem 2001;276:13709-17.
21. Liu D, Kang JS, Derynck R. TGF-β-activated Smad3 represses MEF2-dependent transcription in myogenic differentiation. EMBO J 2004;23:1557-66.
22. Cuenda A, Cohen P. Stress-activated protein kinase-2/p38 and a rapamycin-sensitive pathway are required for C2C12 myogenesis. J Biol Chem 1999;274:4341-6.
23. Pena TL, Chen SH, Konieczny SF, Rane SG. Ras/MEK/ERK Up-regulation of the fibroblast KCa channel FIK is a common mechanism for basic fibroblast growth factor and transforming growth factor-β suppression of myogenesis. J Biol Chem 2000;275:13677-82.
24. Yang W, Wang K, Chen Y, Zhang Y, Huang B, Zhu D. Functional characterization of recombinant myostatin and its inhibitory role to chicken muscle development. Acta Biochim Biophys Sin 2003;35:1016-22.
25. Yang W, Zhang Y, Ma G, Zhao X, Chen Y, Zhu D. Identification of gene expression modifications in myostatin-stimulated myoblasts. Biochem Biophys Res Commun 2005;326:660-6.
26. Lee KS, Hong SH, Bae SC. Both the Smad and p38 MAPK pathways play a crucial role in Runx2 expression following induction by transforming growth factor-β and bone morphogenetic protein. Oncogene 2002;21:7156-63.
27. Undevia NS, Dorscheid DR, Marroquin BA, Gugliotta WL, Tse R, White SR. Smad and p38-MAPK signaling mediates apoptotic effects of transforming growth factor-β1 in human airway epithelial cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L515-24.
28. Xiao YQ, Malcolm K, Worthen GS, et al. Cross-talk between ERK and p38 MAPK mediates selective suppression of pro-inflammatory cytokines by transforming growth factor-β. J Biol Chem 2002;277:14884-93.
29. McCroskery S, Thomas M, Maxwell L, Sharma M, Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003;162:1135-47.
30. Penn BH, Berkes CA, Bergstrom DA, Tapscott SJ. How to MEK muscle. Mol Cell 2001;8:245-6.
31. Joneson T, Bar-Sagi D. Ras effectors and their role in mitogenesis and oncogenesis. J Mol Med 1997;75:587-93.
32. Kang CD, Do IR, Kim KW, et al. Role of Ras/ERK-dependent pathway in the erythroid differentiation of K562 cells. Exp Mol Med 1999;31:76-82.
33. Winter B, Arnold HH. Activated raf kinase inhibits muscle cell differentiation through a MEF2-dependent mechanism. J Cell Sci 2000;113:4211-20.
34. Johnson SE, Dorman CM, Bolanowski SA. Inhibition of myogenin expression by activated Raf is not responsible for the block to avian myogenesis. J Biol Chem 2002;277:28742-8.
35. Wang X, Thomson SR, Starkey JD, Page JL, Ealy AD, Johnson SE. Transforming growth factor β1 is upregulated by activated Raf in skeletal myoblasts but does not contribute to the differentiation-defective phenotype. J Biol Chem 2004;279:2528-34.
36. Shi Y, Massague J. Mechanisms of TGF-β signaling from cell membrane to the nucleus. Cell 2003;113:685-700.